Maravai LifeSciences Holdings, Inc. reported a workforce reduction affecting about 25% of its employees on August 11, 2025, as part of a restructuring effort, estimating costs between $8.0 million and $9.0 million related to severance. Additionally, on August 7, 2025, the company announced the termination of two executives, impacting their employment by September and October 2025.